Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10594353rdf:typepubmed:Citationlld:pubmed
pubmed-article:10594353lifeskim:mentionsumls-concept:C0206558lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0024398lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0009013lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0175727lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:10594353lifeskim:mentionsumls-concept:C0449435lld:lifeskim
pubmed-article:10594353pubmed:issue1-2lld:pubmed
pubmed-article:10594353pubmed:dateCreated2000-1-7lld:pubmed
pubmed-article:10594353pubmed:abstractTextHerpesvirus saimiri (HVS), a nonhuman primate gamma herpes virus, was used to immortalize pig-tailed macaque CD4(+) T lymphocytes. The HVS-immortalized T cell lines were used to develop CD4(+) T cell clones from two animals. Three CD4(+) T cell clones were further characterized for the expression of cell surface markers. All expressed CD2, CD4, CD58, CD69 and CD80 and therefore resembled activated T cells. These clones required exogenous IL-2 for efficient growth and were found to be highly susceptible to infection by the challenge virus, Chimeric simian/human immunodeficiency virus (SHIV(KU-1)). They could also be productively infected not only by the quasispecies of the challenge virus (SHIV(KU-1/PDJ) and SHIV(KU-1/PNA), isolated from macaque PDj and PNa, respectively) but also by a different chimeric simian/human immunodeficiency virus (SHIV(89.6P)) and simian immunodeficiency virus (SIV(MAC239)). The virus-infected CD4(+) T cell clones were also used as stimulators for generation of CTL effectors. These effectors exhibited excellent virus-specific lysis in chromium-release assays when syngenic SHIV(KU-1) infected autologous CD4(+) T cell clones were used as targets. The target cell lysis was virus specific, as uninfected control cells showed no or minimal lysis.lld:pubmed
pubmed-article:10594353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:languageenglld:pubmed
pubmed-article:10594353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:citationSubsetIMlld:pubmed
pubmed-article:10594353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10594353pubmed:statusMEDLINElld:pubmed
pubmed-article:10594353pubmed:monthNovlld:pubmed
pubmed-article:10594353pubmed:issn0022-1759lld:pubmed
pubmed-article:10594353pubmed:authorpubmed-author:KumarAAlld:pubmed
pubmed-article:10594353pubmed:authorpubmed-author:NarayanOOlld:pubmed
pubmed-article:10594353pubmed:authorpubmed-author:ShefferDDlld:pubmed
pubmed-article:10594353pubmed:authorpubmed-author:StippH LHLlld:pubmed
pubmed-article:10594353pubmed:issnTypePrintlld:pubmed
pubmed-article:10594353pubmed:day19lld:pubmed
pubmed-article:10594353pubmed:volume230lld:pubmed
pubmed-article:10594353pubmed:ownerNLMlld:pubmed
pubmed-article:10594353pubmed:authorsCompleteYlld:pubmed
pubmed-article:10594353pubmed:pagination47-58lld:pubmed
pubmed-article:10594353pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:meshHeadingpubmed-meshheading:10594353...lld:pubmed
pubmed-article:10594353pubmed:year1999lld:pubmed
pubmed-article:10594353pubmed:articleTitleUse of herpesvirus saimiri-immortalized macaque CD4(+) T cell clones as stimulators and targets for assessment of CTL responses in macaque/AIDS models.lld:pubmed
pubmed-article:10594353pubmed:affiliationMarion Merrell Dow Laboratory of Viral Pathogenesis and Department of Microbiology, Molecular Genetics and Immunology, University Kansas Medical Center, Kansas City, KS 66160, USA. akumar@kumc.edulld:pubmed
pubmed-article:10594353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10594353pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10594353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10594353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10594353lld:pubmed